2020
$189M
from 6 investors over 6 rounds
Repertoire Immune Medicines raised $189M on April 13, 2021
Investors: Alaska Permanent Fund Corporation, The Invus Group, SoftBank Investment Advisers and Flagship Ventures
Repertoire Immune Medicines raised undisclosed on March 25, 2020
Investors: JDRF T1D Fund
Repertoire Immune Medicines raised $25M on November 14, 2017
Investors: Flagship Ventures